| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/07/2001 | WO2001040467A1 Human cytokine receptor |
| 06/07/2001 | WO2001040466A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | WO2001040465A2 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | WO2001040464A1 Interleukin-1-receptor associated kinase-3 (irak3) and its use in promotion or inhibition of angiogenesis and cardiovascularization |
| 06/07/2001 | WO2001040462A1 Method for measuring the extent of skin aging and measurement kit |
| 06/07/2001 | WO2001040460A1 Screening method for compounds capable of modularing egr-1-regulated expression |
| 06/07/2001 | WO2001040457A1 Semaphorin receptor |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040454A1 Method and apparatus for selectively targeting specific cells within a cell population |
| 06/07/2001 | WO2001040451A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | WO2001040446A1 Pour-on formulations |
| 06/07/2001 | WO2001040305A1 Novel abcb9 transporter and uses thereof |
| 06/07/2001 | WO2001040303A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | WO2001040279A2 Hbv sequences |
| 06/07/2001 | WO2001040276A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 06/07/2001 | WO2001040274A2 Inhibition of hrsv membrane fusion |
| 06/07/2001 | WO2001040271A2 Cancer associated antigens and uses therefor |
| 06/07/2001 | WO2001040261A1 Method of diagnosing neurodegenerative disease |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040249A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001039806A1 Receptor binding conjugates |
| 06/07/2001 | WO2001039798A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | WO2001039786A2 New uses of suppressive macrophage activation factors |
| 06/07/2001 | WO2001039784A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | WO2001032912A8 Use of the jak-stat system in cultured cells to trace effects of tested compounds |
| 06/07/2001 | WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 06/07/2001 | WO2001020337A8 Genetic testing for periodontitis based on cathepsin c |
| 06/07/2001 | WO2001018549A8 Method for identifying modulators of daf-16 |
| 06/07/2001 | WO2001012854A3 Color compensation for temperature and electronic gains |
| 06/07/2001 | WO2001012843A3 Hydrogen peroxide monitoring |
| 06/07/2001 | WO2001012798A3 Male sterile plants |
| 06/07/2001 | WO2001011071A3 Bioproduction of para-hydroxycinnamic acid |
| 06/07/2001 | WO2001011064A3 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 06/07/2001 | WO2001010902A3 Nucleoc acids and secreted polypeptides encoded thereby |
| 06/07/2001 | WO2001010384A3 Method for identifying compounds for treatment of insulin resistance |
| 06/07/2001 | WO2001009384A3 Serial analysis of genetic alterations |
| 06/07/2001 | WO2001009311A3 Methods of inhibiting cancer cells with adnf iii antisense oligonucleotides |
| 06/07/2001 | WO2001007645A3 Method for marking solid, liquid and gaseous substances |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO2000037683A3 HIGH THROUGHPUT ASSAY SYSTEM FOR MONITORING ESTs |
| 06/07/2001 | WO2000032752A9 Psca: prostate stem cell antigen and uses thereof |
| 06/07/2001 | WO2000009710A3 Compositions and methods for identifying mammalian malonyl coa decarboxylase inhibitors, agonists and antagonists |
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
| 06/07/2001 | US20010003045 Providing a chemical sensor having a layer with one or more apertures for diffusional flux rate controll and controlling stoichiometric ratio of co-reactants such as oxygen and analyte such as glucose entering an enzyme layer |
| 06/07/2001 | DE19958160A1 Neue für das gpm-Gen codierende Nukleotidsequenzen New coding for the gpm gene nucleotide sequences |
| 06/07/2001 | DE10056338A1 Treatment of a medium, especially waste water, with microorganisms from bioreactor comprises controlling bioreactor in response to physical, chemical and/or biochemical parameter of medium |
| 06/07/2001 | CA2822851A1 Improved flow cytometer nozzle and flow cytometer sample handling methods |
| 06/07/2001 | CA2739572A1 Improved flow cytometer nozzle and flow cytometer sample handling methods |
| 06/07/2001 | CA2709291A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2496312A1 Colon tumour marker pro4799 polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2494705A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2492070A1 Lung tumor marker pro4329 polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2492049A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2491610A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2491433A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2491258A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2490909A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2490853A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2406316A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | CA2394996A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | CA2394142A1 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 06/07/2001 | CA2393422A1 A method for high throughput thermodynamic screening of ligands |
| 06/07/2001 | CA2393369A1 Human cytokine receptor |
| 06/07/2001 | CA2393360A1 Targeted methods of drug screening using co-culture methods |
| 06/07/2001 | CA2393136A1 Evaluating and predicting clinical outcomes by gene expression analysis |
| 06/07/2001 | CA2393115A1 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 06/07/2001 | CA2393041A1 Method for obtaining nucleic acids from an environment sample, resulting nucleic acids and use in synthesis of novel compounds |
| 06/07/2001 | CA2393004A1 Method of diagnosing neurodegenerative disease |
| 06/07/2001 | CA2392991A1 Semaphorin receptor |
| 06/07/2001 | CA2392981A1 Direct screening method |
| 06/07/2001 | CA2392963A1 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity |
| 06/07/2001 | CA2392948A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | CA2392946A1 Novel abcb9 transporter and uses thereof |
| 06/07/2001 | CA2392853A1 Hbv sequences |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392693A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392615A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | CA2392534A1 Method and apparatus for selectively targeting specific cells within a cell population |
| 06/07/2001 | CA2392508A1 Method of judging flocculating properties of bottom brewer's yeast |
| 06/07/2001 | CA2391455A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2391404A1 Udp-glucose:aglycon-glucosyltransferase |
| 06/07/2001 | CA2391402A1 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2390415A1 New uses of suppressive macrophage activation factors |
| 06/07/2001 | CA2390088A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | CA2388834A1 Method for detecting and evaluating a potentially aberrantly methylated dna region on the x chromosome or the clonality |
| 06/07/2001 | CA2388205A1 Schizophrenia associated gene, proteins and biallelic markers |
| 06/07/2001 | CA2360342A1 Generation of single-strand circular dna from linear self-annealing segments |
| 06/06/2001 | EP1104883A2 Improved sensor membranes |
| 06/06/2001 | EP1104814A2 Method for predicting risk of developing chronic pulmonary emphysema |
| 06/06/2001 | EP1104812A1 Nucleotide sequences coding for the gpm gene |
| 06/06/2001 | EP1104808A1 ESTs and encoded human proteins |
| 06/06/2001 | EP1104769A2 Modified green fluorescent proteins |
| 06/06/2001 | EP1104687A2 Nucleic acid-immobilized substrate |
| 06/06/2001 | EP1104492A1 Subtle mitochondrial mutations as tumor markers |
| 06/06/2001 | EP1104491A1 Methods and systems for sequencing dna by distinguishing the decay times of fluorescent probes |
| 06/06/2001 | EP1104490A1 Method of detecting a dna sequence, a dna sequence, a method of making a dna construct and the use thereof |
| 06/06/2001 | EP1104489A1 Method for separating and characterising functions potentially present in a biological sample containing nucleic acids |
| 06/06/2001 | EP1104488A1 Linking gene sequence to gene function by three dimensional (3d) protein structure determination |